OA|E-mail|Chinese TEL:400-0572-666
HOME > R&D > R&D Strength
R&D Strength


Zhejiang Conba Pharmaceutical R&D Co., Ltd., a professional R&D institute wholly-owned and managed by Zhejiang Conba Pharmaceutical Co., Ltd., owns independent legal personality, has built sophisticated new drug R&D technology and service system, owns a R&D technology team with strong technological force and rich practical experience with more than 60% masters or above, meanwhile, it has established good long-term cooperative relationship with several domestic and international research institutes and professional drug research institutions. The company is committed to fully utilizing its domestic and foreign research cooperation advantages, aiming at the strategic development needs of stock companies and groups, developing and providing advanced new drug products with independent intellectual property right and actively providing technical support for enterprises’ production and operation. The company has had the full independent research capacity in carrying out standard clinical research, applying for production and obtaining new drug certificate, improving production batch and technology and enhancing quality standards, etc.
Zhejiang modern Chinese medicine and natural medicine institute, a wholly owned subsidiary of Conba Group, Co., Ltd, was founded in 2002 with a registered capital of RMB 40 million. It is a high-tech enterprise and the only private institute approved by Science Technology Department of Zhejiang Province in Zhejiang to specialize in Chinese medicine and natural medicine R&D and was rated as "Zhejiang Provincial Genetic Technology Service Center for Small and Medium-sized Enterprises" in 2007. It is a R&D institute specialized in drug R&D, new drug application and new drug R&D project investment, etc. Since its establishment, it has won 32 new drug certificates, 8 of which are above Class II, and undertaken two national projects, 863 and the 11th Five-Year Support, and a number of provincial projects. It owns strong drug R&D capacity in deep R&D in the aspects of pharmacological screening research, function mechanism research and preclinical research of natural medicine and herbal medicine by utilizing modern medicine technology.
At the same time, Zhejiang Conba Pharmaceutical Co., Ltd. has built a 2500m2 new drug pilot research center in Lanxi National Natural Medicine Industrial Park, which has set up Chinese medicine extraction, separation and purification pilot platform by adopting modern extraction technology and equipment where explosion-proof online detection can be achieved; is able to carry out new products industrialized technology research and old products key production technology research, discover amplification rules and reduce amplification effect, provide scientific basis for the determination of process parameters for Industrial mass production and provide pilot services for research institutes and enterprises in or outside the company.
In addition, relying on the subordinate high-tech enterprises, the company has also set up a number of provincial R&D centers, such as Zhejiang Conba Modern Herbal Medicine Provincial Technology R&D Center (Lanxi), Conba New-type Preparations Provincial Technology R&D Center (Hangzhou), Jinhua Conba Biopharmaceutical Provincial Technology R&D Center (Jinhua), Jiangxi Provincial TCMI Engineering Technology Research Center (Yingtan), Jiangxi Zhenshiming Enterprise Technology Center (Fuzhou).